Predictive factors for glucocorticoid therapy in children with eosinophilic gastroenteritis

Zhongguo Dang Dai Er Ke Za Zhi. 2021 Nov 15;23(11):1149-1153. doi: 10.7499/j.issn.1008-8830.2108089.
[Article in English, Chinese]

Abstract

Objectives: To study the predictive factors for glucocorticoid therapy by analyzing the association between the clinical features and treatment regimens in children with eosinophilic gastroenteritis.

Methods: A retrospective analysis was performed on the medical data of 182 children with eosinophilic gastroenteritis who were admitted to Guangzhou Women and Children's Medical Center from January 2012 to December 2020. According to whether glucocorticoids were used, these children were divided into a glucocorticoid treatment group and a control group. The two groups were compared in terms of age, history of allergy, clinical symptoms, laboratory examination results, endoscopic findings, and pathological results of gastrointestinal mucosa. A multivariate logistic regression analysis was performed for the results with statistical significance.

Results: Of the 182 children, 36 (19.8%) received glucocorticoid therapy. The rates of hematochezia, anemia, and mucosal ulceration/luminal stenosis under endoscopy and the mucosal eosinophil infiltration count were significantly higher in the glucocorticoid treatment group than those in the control group (P<0.05). The serum albumin level in the glucocorticoid treatment group was significantly lower than that in the control group (P<0.05). The multivariate logistic regression analysis showed that mucosal ulceration/luminal stenosis under endoscopy (OR=10.830, 95%CI: 3.090-37.961, P<0.001) and the increased mucosal eosinophil infiltration count (OR=0.967, 95%CI: 0.941-0.993, P=0.015) were predictive factors for glucocorticoid therapy in children with eosinophil gastroenteritis.

Conclusions: Mucosal ulceration/luminal stenosis under endoscopy or a significant increase in the mucosal eosinophil infiltration count based on pathology suggests that glucocorticoid therapy can be considered in children with eosinophil gastroenteritis.

目的: 分析儿童嗜酸性粒细胞性胃肠炎临床特点和治疗方案的关系,探讨糖皮质激素治疗的适用情况,为儿科医师选择治疗方案提供依据。方法: 回顾性收集广州市妇女儿童医疗中心2012年1月至2020年12月收治的182例嗜酸性粒细胞性胃肠炎患儿的临床资料。根据治疗方案中是否使用糖皮质激素分为激素组和对照组,比较分析两组患儿年龄、过敏史、临床症状、实验室检查结果、内镜下表现和胃肠黏膜病理结果,对差异有统计学意义的结果进一步行logistic回归分析。结果: 182例患儿中,36例使用糖皮质激素治疗,占总人数的19.8%。激素组患儿出现血便、贫血,内镜下出现黏膜溃疡/管腔狭窄的比例,以及黏膜嗜酸性粒细胞浸润计数均明显高于对照组(n=146,P<0.05);激素组血清白蛋白水平明显低于对照组(P<0.05)。多因素logistic回归分析结果显示,内镜下见黏膜溃疡/管腔狭窄(OR=10.830,95%CI:3.090~37.961,P<0.001)和黏膜嗜酸性粒细胞浸润计数升高(OR=0.967,95%CI:0.941~0.993,P=0.015)可提示使用糖皮质激素治疗儿童嗜酸性粒细胞性胃肠炎。结论: 内镜下见到黏膜溃疡/管腔狭窄,病理显示黏膜嗜酸性粒细胞浸润计数明显升高,均提示儿童嗜酸性粒细胞性胃肠炎的治疗方案中可采用糖皮质激素治疗。.

Keywords: Child; Eosinophilic gastroenteritis; Glucocorticoid.

MeSH terms

  • Child
  • Enteritis* / drug therapy
  • Eosinophilia* / drug therapy
  • Female
  • Gastritis
  • Glucocorticoids / therapeutic use
  • Humans
  • Retrospective Studies

Substances

  • Glucocorticoids

Supplementary concepts

  • Eosinophilic enteropathy